企业
Synthace
a University College London spinout that operated as a synthetic biology company before pivoting fully to software in 2017; its cloud-based Digital Experiment Platform automates design-of-experiments for complex biological processes, validated by AstraZeneca, GSK and Charles River.
- 国家
- United Kingdom
Pharma-Validated
EU
覆盖范围
| CN | EU | US | |
|---|---|---|---|
| foundries-design | ✓ | ✓ | ✓ |
监管机构fdaema
技术
| 名称 | 集群 | 风险 | |
|---|---|---|---|
| 合成生物学CAD软件 | foundries-design | 中 | → |
由 BIOECON 依据一手资料编制。
合规
Bioecon 是信息中介,并非监管机构、认证机构或法律顾问。在与公共部门客户合作时 (依据 44-FZ / 223-FZ 的采购),Bioecon 仅作为独立分析平台,不收取供应商任何报酬。